Serology
Inconsistencies in Reporting Anti-Streptolysin O: A Five Year Review
Microbiology
Vancomycin Resistant Enterococci (VRE) screening quality assurance program: a five-year review of methods and performance
Haematology
Ongoing improvements in laboratory performance of coagulation factors VIII and IX: Recent experience from the RCPAQAP
Anatomical Pathology
The challenges of implementing a PD-L1 proficiency testing program
Malaria Parasite Proficiency Testing - 11 year Review
Molecular Genetics
High rates of variation in HLA-DQ2/DQ8 diagnostic testing: Results from an RCPAQAP coeliac disease pilot program
Cytopathology
Quest for Quality in Digital Cytopathology
Review of Factor XIII Screen Versus Assay: Results from the RCPAQAP
KIMMS
2nd KIMMS workshop. Where to now?
Chemical Pathology
Introduction of a Body Fluids External Quality Assurance Program
Stability of Lyophilised General Serum Chemistry QAP Materia
A Five-year Review: External Quality Assurance of Hereditary Haemochromatosis Testing
Icterus Assessment in an external quality assurance program
Total Pathway to Method Validation
External quality assurance within the renewed National Cervical Screening Program – a preliminary analysis
External Quality Assurance In Malarial Parasite Density Counts
Evaluation of diagnostic testing for IDH1 and IDH2 gene variants in acute myeloid leukaemia
Informatics
Informatics External Quality Assurance (IEQA) Down Under: Evaluation of a pilot implementation
Business Development
From Compliance to Excellence – the RCPAQAP and the Australian Business Excellence Framework (ABEF)
Environmental Management System Committee
Achieving Environmental Management Systems (ISO 14001) Certification at the RCPAQAP
Unfractionated Heparin monitoring with Activated Partial Thromboplastin Time – RCPAQAP Questionnaire review
RCPAQAP Pilot Program for Strongyloides Detection
Risk in Pathology as measured by KIMMS
Synovial Fluid
Preservation of Synovial Fluid with Dimethyl Sulfoxide (DMSO)
Investigating the Effects of Lyophilisation on General Serum Chemistry EQA Material for Routine Measurands
A KIMMS survey on high risk results handover
Anti-Müllerian Hormone: Results from the RCPAQAP Pilot Program
Establishment of a real-time external quality assurance program
Introduction of a calibrator category to differentiate new Troponin reagent releases
The Changing Face of Activated Protein C Resistance Testing – A 10 Year Review
Evaluating a Strongyloides EQA Program: Outcomes of a two-year pilot study
Fresh Whole Blood Immunosuppressants Program Review
The Royal College of Pathologists of Australasia Quality Assurance Programs 10 year review of INR
Challenges of producing a new external quality assurance program
Malarial Parasite Rapid Diagnostic Testing – A Performance Review
Bone Marrow Morphology Proficiency Testing – A Virtual Experience
Immunology
Evaluation of a virtual ANA External Quality Assurance Challenge
Neutralisation of Rivaroxaban Induced Interference by DOAC Stop and Andexanet Alfa
Highlighting the need for harmonisation of G6PD reporting following the introduction of new antimalarials
Challenging the robustness of plasma free metanephrine methods – Are laboratories hydrolyzing samples?
Single vs Dual platform: CD34+ External Quality Assurance Program, a fi ve year review
High variation in reporting of CD21lo B cell population during a pilot external Quality Assurance Program
